MedPath

Pre-operative Tamsulosin and Time to Spontaneous Void After Hysterectomy

Phase 2
Completed
Conditions
Urinary Retention Postoperative
Interventions
Drug: Placebo
Registration Number
NCT04859660
Lead Sponsor
University of Arizona
Brief Summary

The aim of this study is to determine if a one time dose of tamsulosin given pre-operatively decreases the time to void and the time to discharge after minimally invasive hysterectomy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
161
Inclusion Criteria
  • Women 18-80 undergoing outpatient minimally invasive hysterectomy
Exclusion Criteria
  • Inability to provide informed consent
  • Bladder malignancy
  • Intra-operative bladder or ureteral injury; anticipated prolonged bladder catheterization
  • Plan for sling or anterior repair

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Tamsulosin- intervention groupTamsulosin-
Placebo groupPlacebo-
Primary Outcome Measures
NameTimeMethod
Time to Spontaneous Void8 weeks

Each participant underwent a void trial post-operatively by backfilling their bladder with 200cc normal saline at the conclusion of the case and removing the foley. Patients needed to void at least 100cc to be considered to have "passed" their void trial.

Secondary Outcome Measures
NameTimeMethod
Time to Discharge From the Post-anesthesia Care Unit8 weeks

The time from the patient leaving the OR to the time they were discharged home from the Post-anesthesia care unit was recorded to determine the Time to discharge.

Trial Locations

Locations (2)

Banner University Medical Center- Phoenix

🇺🇸

Phoenix, Arizona, United States

Banner University Medical Center- Tucson

🇺🇸

Tucson, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath